Gujarat Inject Kerala Limited

• Board approved audited standalone financial results for Q4 and FY ended March 31, 2026 with unmodified audit opinion. • FY26 net profit increased 78% to ₹181.41 lakh from ₹101.72 lakh in FY25, while